From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle
Layoffs Hit Biotech Hubs Hard In labs from Boston’s Kendall
Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding
In a significant stride towards ethical biomedical advancements, Brisbane-based biotech
UroGen Aims to Raise $107M to Advance Innovative Obesity and Bladder Cancer Therapies
Introduction Overview of UroGen: UroGen Pharma Ltd., headquartered in Princeton,
Diamond Biofund Becomes First Biotech VC Firm Listed on Taiwan Stock Exchange
Introduction: Diamond Biofund has recently achieved a groundbreaking milestone by
Marea Biotech Secures $190 Million for Heart Disease Research
Introduction Marea Biotech, a pioneering company in the biotech industry,
MOST POPULAR
